Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: A randomized, controlled, double-blind trial

Gastroenterology

Volumn 123, Issue 1, 2002, Pages 17-23

  Frossard, Jean Louis ^a   Spahr, Laurent ^a   Queneau, Pierre Edouard ^a   Giostra, Emiliano ^a   Burckhardt, Beat ^a   Ory, Gaëlle ^a   De Saussure, Philippe ^a   Armenian, Berj ^a   De Peyer, Raymond ^a   Hadengue, Antoine ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; PLACEBO;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEMATEMESIS; HUMAN; LENGTH OF STAY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STOMACH EMPTYING; TIME;

EID: 0036302202     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.34230     Document Type: Article

References (37)

1. Clinical findings, early endoscopy and multivariate analysis in patients bleeding from the upper gastrointestinal tract
2. The national ASGE survey on upper gastrointestinal bleeding
3. The non-bleeding visible vessel versus the sentinel clot: Natural history and risk of rebleeding
4. Refining the prognostic value of endoscopy in patients presenting with bleeding ulcers
5. Bleeding peptic ulcer
6. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A metaanalysis
7. Endoscopic hemostasis: An effective therapy for bleeding peptic ulcers
8. Gastrointestinal endoscopy
9. Bleeding peptic ulcer: Pathogenesis and endoscopic therapy
10. Sclerotherapy with or without octreotide for acute variceal bleeding
11. Failures of endoscopic therapy for bleeding peptic ulcer: An analysis of risk factors
12. Factors predicting failure of endoscopic injection therapy in bleeding duodenal ulcer
13. Choosing the right macrolide antibiotic
14. Erythromycin accelerates solid emptying at the expense of gastric sieving
15. Erythromycin: A motilin agonist and gastrointestinal prokinetic agent
16. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog
17. Erythromycin is a motilin receptor agonist
18. Therapeutic endoscopy for nonvariceal gastrointestinal bleeding
19. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): Case report and review
20. Torsades de pointes induced by erythromycin and terfenadine
21. Pharmacokinetic drug interactions of macrolides
22. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: The European acute bleeding oesophageal variceal episodes (ABOVE) randomised trial
23. Sore points. A review of the points where there was disagreement at Baveno I and an attempt to reach consensus
24. Nonvariceal upper gastrointestinal bleeding: An update
25. Bleeding peptic ulcer-risk factors for rebleeding and sequential changes in endoscopic features
26. A comparison of omeprazole and placebo for bleeding peptic ulcer
27. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers
28. The effect of erythromycin on gastric emptying is modified by physiological changes in the blood glucose concentration
29. Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding
30. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies
31. Upper gastrointestinal bleeding
32. The association of age with gastric emptying
33. Effects of aging and gastric lipolysis on gastric emptying of lipid in liquid meal
34. Gastrointestinal tract hemorrhage: The value of a nasogastric aspirate
35. Erythromycin, clarithromycin and azithromycin: Are the differences real?
36. Comparative safety of the different macrolides
37. Adverse effects of macrolide antibacterials